The real-time blood glucose cgm patch market size has grown rapidly in recent years. It will grow from $7.05 billion in 2025 to $7.77 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to rising diabetes prevalence, limitations of finger-prick testing, wearable medical device adoption, patient self-monitoring demand, healthcare digitalization.
The real-time blood glucose cgm patch market size is expected to see rapid growth in the next few years. It will grow to $11.57 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to AI-based glucose prediction, telehealth integration, preventive diabetes management, remote patient monitoring expansion, reimbursement policy support. Major trends in the forecast period include continuous glucose monitoring wearables, needle-free glucose tracking, real-time glucose alerts, long-duration wearable patches, improved sensor accuracy.
The rising adoption of remote monitoring and telehealth is expected to enhance the growth of the real time blood glucose CGM patch market in the coming years. Remote monitoring refers to the use of digital technologies to collect and transmit a patient’s health data, such as blood glucose levels, heart rate, or blood pressure, from outside traditional clinical settings to healthcare providers for continuous assessment and management. Telehealth adoption involves the growing use of virtual healthcare services, including video consultations, remote follow ups, and digital communication between patients and healthcare providers. The adoption of remote monitoring and telehealth is increasing due to rising demand for convenient and accessible healthcare services, particularly for managing chronic conditions such as diabetes. Real time blood glucose CGM patches support this trend by enabling continuous, real time data sharing with healthcare providers, allowing timely interventions and effective virtual diabetes management. For example, in February 2025, according to the American Hospital Association, a U.S. based national organization, the United States is expected to face a shortage of up to 86,000 physicians by 2036, emphasizing the crucial role of telehealth in addressing this healthcare gap. Therefore, the rising adoption of remote monitoring and telehealth is enhancing the growth of the real time blood glucose CGM patch market.
Prominent players operating in the real-time blood glucose continuous glucose monitoring (CGM) patch market are emphasizing the development of advanced products, such as water-resistant sensors, to improve user convenience and ensure reliable continuous monitoring. A water-resistant sensor is an advanced device engineered to operate accurately and consistently even when exposed to water or perspiration, safeguarding its internal components from potential damage. For example, in February 2024, Dexcom Inc., a United States-based medical device manufacturer, introduced the Dexcom ONE+, a real-time continuous glucose monitoring system in Spain, Belgium, and Poland. The system delivers a compact, highly accurate, and user-friendly CGM solution that provides real-time glucose readings around the clock with customizable alerts, including a unique delay-first high notification to minimize alarm fatigue. It features an integrated water-resistant sensor compatible with multiple wear locations, a fast 30-minute warm-up period, a 10-day sensor life with a 12-hour grace window for replacement, and seamless connectivity to smartphones and receivers, facilitating effective and continuous diabetes management.
In April 2025, Cardinal Health Incorporated, a US-based healthcare company, acquired Advanced Diabetes Supply Group (ADSG) for an undisclosed amount. Through this acquisition, Cardinal Health aims to expand its at-home solutions business, reach more patients with innovative diabetes care, accelerate growth within the expanding diabetes population, and enhance patient-centric care delivery. Advanced Diabetes Supply Group is a US-based medical equipment distributor that provides real-time continuous glucose monitoring (CGM) patches.
Major companies operating in the real-time blood glucose cgm patch market are Abbott Laboratories, Dexcom Inc., Medtronic plc, Senseonics Holdings Inc., Medtrum Technologies Inc., Zhejiang POCTech Co. Ltd., MicroTech Medical Inc., Biolinq Inc., Metronom Health Inc., Afon Technology Ltd., Nemaura Medical Inc., Ultrahuman Healthcare Pvt. Ltd., PKvitality SAS, EOFlow Co. Ltd., i-SENS Inc., SiBio Technology Co. Ltd., Sinocare Inc., GlucoTrack Inc., Know Labs Inc., LifePlus Inc.
North America was the largest region in the real-time blood glucose continuous glucose monitoring (CGM) patch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time blood glucose cgm patch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the real-time blood glucose cgm patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased costs of imported biosensors, microelectronics, and adhesives used in wearable and implantable CGM patches, particularly affecting Asia-Pacific manufacturing hubs supplying North America and Europe. These cost pressures have slowed adoption in price-sensitive regions, but they are also driving domestic production, component localization, and innovation in cost-efficient CGM patch designs.
The real-time blood glucose cgm patch market research report is one of a series of new reports that provides real-time blood glucose cgm patch market statistics, including real-time blood glucose cgm patch industry global market size, regional shares, competitors with a real-time blood glucose cgm patch market share, detailed real-time blood glucose cgm patch market segments, market trends and opportunities, and any further data you may need to thrive in the real-time blood glucose cgm patch industry. This real-time blood glucose cgm patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A real-time blood glucose continuous glucose monitoring (CGM) patch refer to a wearable medical device that continuously measures glucose levels in the interstitial fluid beneath the skin, providing real-time data. It helps individuals with diabetes track blood sugar trends, identify fluctuations, and make timely adjustments to insulin or diet for improved glycemic control. These patches minimize the need for frequent finger-prick tests while supporting proactive glucose management.
The key product types of real-time blood continuous glucose monitoring (CGM) patches include wearable continuous glucose monitoring patches and implantable continuous glucose monitoring patches. A wearable continuous glucose monitoring patch is a digital health device that continuously monitors glucose levels in real time via a sensor applied to the skin, aiding diabetes management, improving glycemic control, and supporting personalized treatment decisions. These patches use technologies such as enzymatic and non-enzymatic sensors and are applied across diabetes conditions including type 1 diabetes, type 2 diabetes, gestational diabetes, and others. They are distributed through channels such as online pharmacies, retail pharmacies, and hospital pharmacies, serving end users including hospitals, clinics, homecare settings, diagnostic centers, and others.
The real-time blood glucose continuous glucose monitoring (CGM) patch market consists of revenues earned by entities by providing services such as continuous glucose monitoring, data analysis and reporting, remote patient monitoring, device maintenance and calibration services, and clinical trial support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The real-time blood glucose continuous glucose monitoring (CGM) patch market also includes sales of long-wear continuous glucose monitoring patches, waterproof continuous glucose monitoring patches, wireless continuous glucose monitoring patches, pediatric continuous glucose monitoring patches, and multi-sensor continuous glucose monitoring patches. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The real-time blood glucose cgm patch market size is expected to see rapid growth in the next few years. It will grow to $11.57 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to AI-based glucose prediction, telehealth integration, preventive diabetes management, remote patient monitoring expansion, reimbursement policy support. Major trends in the forecast period include continuous glucose monitoring wearables, needle-free glucose tracking, real-time glucose alerts, long-duration wearable patches, improved sensor accuracy.
The rising adoption of remote monitoring and telehealth is expected to enhance the growth of the real time blood glucose CGM patch market in the coming years. Remote monitoring refers to the use of digital technologies to collect and transmit a patient’s health data, such as blood glucose levels, heart rate, or blood pressure, from outside traditional clinical settings to healthcare providers for continuous assessment and management. Telehealth adoption involves the growing use of virtual healthcare services, including video consultations, remote follow ups, and digital communication between patients and healthcare providers. The adoption of remote monitoring and telehealth is increasing due to rising demand for convenient and accessible healthcare services, particularly for managing chronic conditions such as diabetes. Real time blood glucose CGM patches support this trend by enabling continuous, real time data sharing with healthcare providers, allowing timely interventions and effective virtual diabetes management. For example, in February 2025, according to the American Hospital Association, a U.S. based national organization, the United States is expected to face a shortage of up to 86,000 physicians by 2036, emphasizing the crucial role of telehealth in addressing this healthcare gap. Therefore, the rising adoption of remote monitoring and telehealth is enhancing the growth of the real time blood glucose CGM patch market.
Prominent players operating in the real-time blood glucose continuous glucose monitoring (CGM) patch market are emphasizing the development of advanced products, such as water-resistant sensors, to improve user convenience and ensure reliable continuous monitoring. A water-resistant sensor is an advanced device engineered to operate accurately and consistently even when exposed to water or perspiration, safeguarding its internal components from potential damage. For example, in February 2024, Dexcom Inc., a United States-based medical device manufacturer, introduced the Dexcom ONE+, a real-time continuous glucose monitoring system in Spain, Belgium, and Poland. The system delivers a compact, highly accurate, and user-friendly CGM solution that provides real-time glucose readings around the clock with customizable alerts, including a unique delay-first high notification to minimize alarm fatigue. It features an integrated water-resistant sensor compatible with multiple wear locations, a fast 30-minute warm-up period, a 10-day sensor life with a 12-hour grace window for replacement, and seamless connectivity to smartphones and receivers, facilitating effective and continuous diabetes management.
In April 2025, Cardinal Health Incorporated, a US-based healthcare company, acquired Advanced Diabetes Supply Group (ADSG) for an undisclosed amount. Through this acquisition, Cardinal Health aims to expand its at-home solutions business, reach more patients with innovative diabetes care, accelerate growth within the expanding diabetes population, and enhance patient-centric care delivery. Advanced Diabetes Supply Group is a US-based medical equipment distributor that provides real-time continuous glucose monitoring (CGM) patches.
Major companies operating in the real-time blood glucose cgm patch market are Abbott Laboratories, Dexcom Inc., Medtronic plc, Senseonics Holdings Inc., Medtrum Technologies Inc., Zhejiang POCTech Co. Ltd., MicroTech Medical Inc., Biolinq Inc., Metronom Health Inc., Afon Technology Ltd., Nemaura Medical Inc., Ultrahuman Healthcare Pvt. Ltd., PKvitality SAS, EOFlow Co. Ltd., i-SENS Inc., SiBio Technology Co. Ltd., Sinocare Inc., GlucoTrack Inc., Know Labs Inc., LifePlus Inc.
North America was the largest region in the real-time blood glucose continuous glucose monitoring (CGM) patch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time blood glucose cgm patch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the real-time blood glucose cgm patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased costs of imported biosensors, microelectronics, and adhesives used in wearable and implantable CGM patches, particularly affecting Asia-Pacific manufacturing hubs supplying North America and Europe. These cost pressures have slowed adoption in price-sensitive regions, but they are also driving domestic production, component localization, and innovation in cost-efficient CGM patch designs.
The real-time blood glucose cgm patch market research report is one of a series of new reports that provides real-time blood glucose cgm patch market statistics, including real-time blood glucose cgm patch industry global market size, regional shares, competitors with a real-time blood glucose cgm patch market share, detailed real-time blood glucose cgm patch market segments, market trends and opportunities, and any further data you may need to thrive in the real-time blood glucose cgm patch industry. This real-time blood glucose cgm patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A real-time blood glucose continuous glucose monitoring (CGM) patch refer to a wearable medical device that continuously measures glucose levels in the interstitial fluid beneath the skin, providing real-time data. It helps individuals with diabetes track blood sugar trends, identify fluctuations, and make timely adjustments to insulin or diet for improved glycemic control. These patches minimize the need for frequent finger-prick tests while supporting proactive glucose management.
The key product types of real-time blood continuous glucose monitoring (CGM) patches include wearable continuous glucose monitoring patches and implantable continuous glucose monitoring patches. A wearable continuous glucose monitoring patch is a digital health device that continuously monitors glucose levels in real time via a sensor applied to the skin, aiding diabetes management, improving glycemic control, and supporting personalized treatment decisions. These patches use technologies such as enzymatic and non-enzymatic sensors and are applied across diabetes conditions including type 1 diabetes, type 2 diabetes, gestational diabetes, and others. They are distributed through channels such as online pharmacies, retail pharmacies, and hospital pharmacies, serving end users including hospitals, clinics, homecare settings, diagnostic centers, and others.
The real-time blood glucose continuous glucose monitoring (CGM) patch market consists of revenues earned by entities by providing services such as continuous glucose monitoring, data analysis and reporting, remote patient monitoring, device maintenance and calibration services, and clinical trial support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The real-time blood glucose continuous glucose monitoring (CGM) patch market also includes sales of long-wear continuous glucose monitoring patches, waterproof continuous glucose monitoring patches, wireless continuous glucose monitoring patches, pediatric continuous glucose monitoring patches, and multi-sensor continuous glucose monitoring patches. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Real-Time Blood Glucose Cgm Patch Market Characteristics
3. Real-Time Blood Glucose Cgm Patch Market Supply Chain Analysis
4. Global Real-Time Blood Glucose Cgm Patch Market Trends and Strategies
5. Real-Time Blood Glucose Cgm Patch Market Analysis of End Use Industries
7. Global Real-Time Blood Glucose Cgm Patch Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Real-Time Blood Glucose Cgm Patch Total Addressable Market (TAM) Analysis for the Market
9. Real-Time Blood Glucose Cgm Patch Market Segmentation
10. Real-Time Blood Glucose Cgm Patch Market Regional and Country Analysis
11. Asia-Pacific Real-Time Blood Glucose Cgm Patch Market
12. China Real-Time Blood Glucose Cgm Patch Market
13. India Real-Time Blood Glucose Cgm Patch Market
14. Japan Real-Time Blood Glucose Cgm Patch Market
15. Australia Real-Time Blood Glucose Cgm Patch Market
16. Indonesia Real-Time Blood Glucose Cgm Patch Market
17. South Korea Real-Time Blood Glucose Cgm Patch Market
18. Taiwan Real-Time Blood Glucose Cgm Patch Market
19. South East Asia Real-Time Blood Glucose Cgm Patch Market
20. Western Europe Real-Time Blood Glucose Cgm Patch Market
21. UK Real-Time Blood Glucose Cgm Patch Market
22. Germany Real-Time Blood Glucose Cgm Patch Market
23. France Real-Time Blood Glucose Cgm Patch Market
24. Italy Real-Time Blood Glucose Cgm Patch Market
25. Spain Real-Time Blood Glucose Cgm Patch Market
26. Eastern Europe Real-Time Blood Glucose Cgm Patch Market
27. Russia Real-Time Blood Glucose Cgm Patch Market
28. North America Real-Time Blood Glucose Cgm Patch Market
29. USA Real-Time Blood Glucose Cgm Patch Market
30. Canada Real-Time Blood Glucose Cgm Patch Market
31. South America Real-Time Blood Glucose Cgm Patch Market
32. Brazil Real-Time Blood Glucose Cgm Patch Market
33. Middle East Real-Time Blood Glucose Cgm Patch Market
34. Africa Real-Time Blood Glucose Cgm Patch Market
36. Real-Time Blood Glucose Cgm Patch Market Competitive Landscape and Company Profiles
37. Real-Time Blood Glucose Cgm Patch Market Other Major and Innovative Companies
40. Real-Time Blood Glucose Cgm Patch Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Real-Time Blood Glucose CGM Patch Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses real-time blood glucose cgm patch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for real-time blood glucose cgm patch? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The real-time blood glucose cgm patch market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Wearable Continuous Glucose Monitoring Patch; Implantable Continuous Glucose Monitoring Patch2) By Technology: Enzymatic; Non-Enzymatic
3) By Application: Type 1 Diabetes; Type 2 Diabetes; Gestational Diabetes; Other Applications
4) By Distribution Channel: Online Pharmacies; Retail Pharmacies; Hospital Pharmacies; Other Distribution Channels
5) By End User: Hospitals And Clinics; Homecare Settings; Diagnostic Centers; Other End Users
Subsegments:
1) By Wearable Continuous Glucose Monitoring Patch: Arm Patches; Abdominal Patches2) By Implantable Continuous Glucose Monitoring Patch: Short-Term Implantable Patches; Long-Term Implantable Patches
Companies Mentioned: Abbott Laboratories; Dexcom Inc.; Medtronic plc; Senseonics Holdings Inc.; Medtrum Technologies Inc.; Zhejiang POCTech Co. Ltd.; MicroTech Medical Inc.; Biolinq Inc.; Metronom Health Inc.; Afon Technology Ltd.; Nemaura Medical Inc.; Ultrahuman Healthcare Pvt. Ltd.; PKvitality SAS; EOFlow Co. Ltd.; i-SENS Inc.; SiBio Technology Co. Ltd.; Sinocare Inc.; GlucoTrack Inc.; Know Labs Inc.; LifePlus Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Real-Time Blood Glucose CGM Patch market report include:- Abbott Laboratories
- Dexcom Inc.
- Medtronic plc
- Senseonics Holdings Inc.
- Medtrum Technologies Inc.
- Zhejiang POCTech Co. Ltd.
- MicroTech Medical Inc.
- Biolinq Inc.
- Metronom Health Inc.
- Afon Technology Ltd.
- Nemaura Medical Inc.
- Ultrahuman Healthcare Pvt. Ltd.
- PKvitality SAS
- EOFlow Co. Ltd.
- i-SENS Inc.
- SiBio Technology Co. Ltd.
- Sinocare Inc.
- GlucoTrack Inc.
- Know Labs Inc.
- LifePlus Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 7.77 Billion |
| Forecasted Market Value ( USD | $ 11.57 Billion |
| Compound Annual Growth Rate | 10.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
